QLT, Inc. (USA) (NASDAQ:QLTI)
CAPS Rating:
A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.
The Official Website of the Long-Term Investor
A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
a company who is supposed to help treat age related macular degeneration, but is blind-sided by it's drug's relative ineffectiveness. Talk about the blind leading the blind!